The United States had surpassed 10 million coronavirus cases as of Monday, November 9. Meanwhile, worldwide infections surpassed 50 million. In Europe, some countries have seen new cases beginning to level off while others are just now reintroducing lockdown and curfew measures this week.
Hope, however, is spreading across the country as Pfizer’s potential vaccine shows more than 90% effectiveness at preventing COVID-19. Pfizer and its collaborator BioNTech released early study results Monday indicating that their vaccine, BNT162b2, prevented more than 90% of infections with the virus that causes COVID-19.
Health care workers who are regularly exposed to COVID-19 are likely to be the first to receive a vaccine, followed by high-risk elderly people, assuming the vaccine works well in them. Even if all goes well, it will be well into 2021 before most Americans can get a vaccine, experts say.
By Kristofel Abella
Ka Lā News staff writer
